Tudor Investment Corp’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-51,242
| Closed | -$1.74M | – | 1694 |
|
|
2025
Q1 | $1.74M | Buy |
51,242
+32,905
| +179% | +$1.12M | 0.01% | 853 |
|
|
2024
Q4 | $722K | Sell |
18,337
-28,662
| -61% | -$1.13M | ﹤0.01% | 1115 |
|
|
2024
Q3 | $2.21M | Buy |
+46,999
| New | +$2.21M | 0.01% | 716 |
|
|
2024
Q2 | – | Sell |
-21,790
| Closed | -$1.49M | – | 1579 |
|
|
2024
Q1 | $1.49M | Buy |
21,790
+5,741
| +36% | +$391K | 0.01% | 771 |
|
|
2023
Q4 | $1M | Buy |
+16,049
| New | +$1M | 0.01% | 930 |
|
|
2023
Q3 | – | Sell |
-25,562
| Closed | -$1.44M | – | 1557 |
|
|
2023
Q2 | $1.44M | Buy |
+25,562
| New | +$1.44M | 0.02% | 765 |
|
|
2023
Q1 | – | Sell |
-24,949
| Closed | -$1.01M | – | 1634 |
|
|
2022
Q4 | $1.01M | Buy |
24,949
+1,056
| +4% | +$42.9K | 0.02% | 842 |
|
|
2022
Q3 | $1.56M | Buy |
23,893
+4,211
| +21% | +$275K | 0.03% | 604 |
|
|
2022
Q2 | $1.2M | Sell |
19,682
-5,301
| -21% | -$322K | 0.03% | 724 |
|
|
2022
Q1 | $1.57M | Sell |
24,983
-4
| -0% | -$251 | 0.04% | 644 |
|
|
2021
Q4 | $1.89M | Buy |
24,987
+3,701
| +17% | +$281K | 0.03% | 617 |
|
|
2021
Q3 | $2.38M | Buy |
+21,286
| New | +$2.38M | 0.04% | 499 |
|
|
2021
Q1 | – | Sell |
-15,841
| Closed | -$2.43M | – | 1570 |
|
|
2020
Q4 | $2.43M | Buy |
15,841
+8,858
| +127% | +$1.36M | 0.07% | 338 |
|
|
2020
Q3 | $584K | Buy |
6,983
+1,916
| +38% | +$160K | 0.03% | 751 |
|
|
2020
Q2 | $372K | Sell |
5,067
-6,182
| -55% | -$454K | 0.02% | 807 |
|
|
2020
Q1 | $477K | Sell |
11,249
-5,484
| -33% | -$233K | 0.04% | 508 |
|
|
2019
Q4 | $1.02M | Buy |
+16,733
| New | +$1.02M | 0.05% | 484 |
|
|
2018
Q2 | – | Sell |
-8,608
| Closed | -$393K | – | 1054 |
|
|
2018
Q1 | $393K | Buy |
+8,608
| New | +$393K | 0.01% | 636 |
|